Live Status Check

NCT03943004 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 2:44 PM UTC

NCT03943004 Status Summary

NCT NumberNCT03943004
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment30 participants
Active Locations2 sites in the US
SponsorDelta-Fly Pharma, Inc.
Last Updated on CT.govMarch 3, 2025 (Mar 3, 2025)

About NCT03943004 Enrollment Status

As of July 13, 2026: Clinical trial NCT03943004 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 2 locations across the United States. The study is sponsored by Delta-Fly Pharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT03943004

Is NCT03943004 still recruiting?

Yes, NCT03943004 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT03943004 recruiting?

This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT03943004?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT03943004 status last updated?

The official ClinicalTrials.gov record for NCT03943004 was last updated Mar 3, 2025 (March 3, 2025). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial